Notal Vision, Inc. news
Manassas, VA (March 8th, 2022) - Digital healthcare provider Notal Vision today announced that results of the first U.S.-based study with its investigational home-based optical coherence tomography (OCT) platform have been published in Ophthalmology Retina1. The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with wet age-related macular degeneration (AMD), complementing existing standard of care treatments as
Manassas, Virginia (November 30, 2021) - The Notal Vision Monitoring Center celebrates the artificial intelligence (Al) based analysis of the ten millionth test performed by over 20,000 patients with the FDA-cleared ForeseeHome device. The device is part of a comprehensive remote monitoring service for intermediate age-related macular degeneration (AMD) patients at risk of developing the sight threatening wet form of the disease. The service monitors patients between office eye exams, when it
Manassas, VA (October 12, 2021) - Notal Vision, Inc. reported today that results of the first U.S.-based feasibility study with its investigational home-based optical coherence tomography (OCT) platform were presented at the Retina Society and the American Society of Retina Specialists (ASRS) annual meetings. The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with wet age-related macular degeneration (AMD), c
Manassas, VA (July 13, 2021) - Notal Vision, Inc. announced today that results from the first prospective longitudinal pilot study of daily, home-based self-imaging with their investigational, patient-operated Home OCT for wet age-related macular degeneration (AMD) patients have been published in Ophthalmology Science.1 The technology is designed to provide retina specialists with remote retinal OCT scans and fluid volume trajectories to support the management of patients with wet AMD, comple
Manassas, VA (June 1, 2021) - Notal Vision, Inc., a privately held ophthalmic home monitoring services provider focused on early disease detection and treatment monitoring is pleased to announce the closing of a Series D financing co-led by Soleus Capital and the company`s majority shareholder Ganot Capital. Existing shareholders Elron and Evergreen contributed significantly to the round. The investment supports the commercial growth of the company`s current service, the ForeseeHome AMD Monit